BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 25705753)

  • 1. Response.
    Edwards NC; McGirt MJ; Engelhart L
    J Neurosurg; 2015 Jan; 122(1):137-8. PubMed ID: 25705753
    [No Abstract]   [Full Text] [Related]  

  • 2. Editorial: industry-sponsored research.
    Kestle JR
    J Neurosurg; 2015 Jan; 122(1):136-8. PubMed ID: 25380108
    [No Abstract]   [Full Text] [Related]  

  • 3. Cost-consequence analysis of antibiotic-impregnated shunts and external ventricular drains in hydrocephalus.
    Edwards NC; Engelhart L; Casamento EM; McGirt MJ
    J Neurosurg; 2015 Jan; 122(1):139-47. PubMed ID: 25380105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibiotic or silver versus standard ventriculoperitoneal shunts (BASICS): a multicentre, single-blinded, randomised trial and economic evaluation.
    Mallucci CL; Jenkinson MD; Conroy EJ; Hartley JC; Brown M; Dalton J; Kearns T; Moitt T; Griffiths MJ; Culeddu G; Solomon T; Hughes D; Gamble C;
    Lancet; 2019 Oct; 394(10208):1530-1539. PubMed ID: 31522843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost savings associated with antibiotic-impregnated shunt catheters in the treatment of adult and pediatric hydrocephalus.
    Parker SL; McGirt MJ; Murphy JA; Megerian JT; Stout M; Engelhart L
    World Neurosurg; 2015 Mar; 83(3):382-6. PubMed ID: 24933241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chhabra hydrocephalus shunt: lessons for gravitational valves.
    Czosnyka Z; Czosnyka M; Richards H; Pickard JD
    J Neurol Neurosurg Psychiatry; 1998 Sep; 65(3):406-7. PubMed ID: 9728968
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of hospital cost and resource use associated with antibiotic-impregnated versus standard shunt catheters.
    Parker SL; Farber SH; Adogwa O; Rigamonti D; McGirt MJ
    Clin Neurosurg; 2011; 58():122-5. PubMed ID: 21916136
    [No Abstract]   [Full Text] [Related]  

  • 8. Cost analysis of antibiotic-impregnated catheters in the treatment of hydrocephalus in adult patients.
    Farber SH; Parker SL; Adogwa O; Rigamonti D; McGirt MJ
    World Neurosurg; 2010; 74(4-5):528-31. PubMed ID: 21492607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of maternal hydrocephalus requires replacement of ventriculoperitoneal shunt with ventriculoatrial shunt: a case report.
    Murakami M; Morine M; Iwasa T; Takahashi Y; Miyamoto T; Hon PK; Nakagawa Y
    Arch Gynecol Obstet; 2010 Sep; 282(3):339-42. PubMed ID: 20157718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparing antibiotic, silver, and standard ventriculoperitoneal shunts.
    Flannery AM
    Lancet; 2019 Oct; 394(10208):1485-1486. PubMed ID: 31522850
    [No Abstract]   [Full Text] [Related]  

  • 11. CSF shunt complications in infants--an experience from Pakistan.
    Bakhsh A
    Pediatr Neurosurg; 2011; 47(2):93-8. PubMed ID: 21822002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of hydrocephalus.
    Wise BL
    J Neurosurg; 2004 Oct; 101(4):719-20; author reply 720-1. PubMed ID: 15481737
    [No Abstract]   [Full Text] [Related]  

  • 13. Cerebrospinal fluid shunt placement in the pediatric population: a model of hospitalization cost.
    Lam SK; Srinivasan VM; Luerssen TG; Pan IW
    Neurosurg Focus; 2014 Nov; 37(5):E5. PubMed ID: 25363433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of programmable versus nonprogrammable shunts in the management of hydrocephalus secondary to aneurysmal subarachnoid hemorrhage: a retrospective study with cost-benefit analysis.
    Lee L; King NK; Kumar D; Ng YP; Rao J; Ng H; Lee KK; Wang E; Ng I
    J Neurosurg; 2014 Oct; 121(4):899-903. PubMed ID: 24745705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydrocephalus and shunts in children with brain tumors.
    Ryan JA; Shiminski-Maher T
    J Pediatr Oncol Nurs; 1995 Oct; 12(4):223-9. PubMed ID: 7495527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. About the rate of shunt complications in patients with hydrocephalus and myelomeningocele.
    Rolle U; Gräfe G
    Eur J Pediatr Surg; 1999 Dec; 9 Suppl 1():51-2. PubMed ID: 10661803
    [No Abstract]   [Full Text] [Related]  

  • 17. Antibiotic-impregnated shunt systems versus standard shunt systems: a meta- and cost-savings analysis.
    Klimo P; Thompson CJ; Ragel BT; Boop FA
    J Neurosurg Pediatr; 2011 Dec; 8(6):600-12. PubMed ID: 22132919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Letter to the Editor: The Preventable Shunt Revision Rate and the measurement of quality in pediatric hydrocephalus.
    Piatt J
    J Neurosurg Pediatr; 2017 Feb; 19(2):270-271. PubMed ID: 27911250
    [No Abstract]   [Full Text] [Related]  

  • 19. Letter to the Editor Regarding "Management of Hydrocephalus with Ventriculoperitoneal Shunts: Review of 109 Cases of Children".
    Santos DE; Chmutin G; Aybar Peña MD; Matos Cuevas YE; Marcel EI; Chaurasia B
    World Neurosurg; 2022 Aug; 164():465-466. PubMed ID: 35941775
    [No Abstract]   [Full Text] [Related]  

  • 20. Proposal for a spiral tube piece in the design of ventriculoperitoneal shunts.
    Akdemir H; Aktas B; Simsek AT; Calis F; Balak N
    Childs Nerv Syst; 2023 Jan; 39(1):9-11. PubMed ID: 36307606
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.